n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® mPCR FMR1 Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
CFTR
Kit
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
HTT
Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X Syndrome
Dementia
Chronic Myeloid Leukemia (CML)
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
Contact
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
December 4, 2018
Asuragen Launches Assay to Aid in the Diagnosis of Myotonic Dystrophy Type I (DM1)
Share
November 13, 2018
Asuragen Announces Health Canada Approval of the QuantideX® qPCR BCR-ABL IS Kit
Share
October 23, 2018
Asuragen to Present at 2018 Association for Molecular Pathology (AMP) Annual Meeting
Share
October 22, 2018
New laboratory screening test for fragile X syndrome shortly after birth now ready for pivotal North Carolina Early Check clinical study
Share
October 16, 2018
Asuragen Announces New Commercial Leadership Appointment
Share
October 9, 2018
Asuragen to Present at 2018 American Society of Human Genetics Annual Meeting
Share
September 25, 2018
Asuragen to Host Panel at Upcoming World Clinical Biomarkers & Companion Diagnostic Summit
Share
September 5, 2018
Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit
Share
July 26, 2018
Asuragen Expands AmplideX® Technology and Product Line with Launch of PCR/CE SMN1 Kit
Share
May 22, 2018
Asuragen to Launch the AmplideX® PCR/CE
DMPK
Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference
Share
Prev
1
2
3
4
5
6
7
8
Next
About
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Back To
Top
